Red blood cell alloimmunization after hematopoietic stem cell transplant: Clinical challenges and implications for donor and recipient—A case report
This case highlights the need for comprehensive immunohematological assessment in HSCT, particularly when rare phenotypes may be involved, and calls for clearer guidelines on communication between transplant centers and donor registries regarding clinically relevant genetic findings.
Authors
- Leandro Dinalli Santos (ORCID: https://orcid.org/0000-0002-7398-1546)
- Andrea Tiemi Kondo (ORCID: https://orcid.org/0000-0002-4228-8503)
- Carolina Bonet Bub (ORCID: https://orcid.org/0000-0001-5103-4970)
- Gabriela Candelária (ORCID: https://orcid.org/0000-0001-8003-3563)
- Luigi Giuseppe Grassi (ORCID: https://orcid.org/0000-0002-1050-4494)
- Nelson Hamerschlak (ORCID: https://orcid.org/0000-0002-5140-5310)
- José Mauro Kutner (ORCID: https://orcid.org/0000-0003-3784-6731)
- Danielli Cristina Muniz de Oliveira
- Mariana Lorenzi Savioli (ORCID: https://orcid.org/0000-0001-5234-9405)
Institutions
- Hospital Israelita Albert Einstein (BR)
- Instituto Nacional de Câncer - INCA (BR)
Publication Details
- Journal
- Transfusion
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1111/trf.18462
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.00